Clinical trial
Post-Approval Study of the PROMUS PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China
NCT03273023 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Approval Study of the PROMUS PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 11, 2018
- Completion date
- October 3, 2025
- Enrollment
- 2,059 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.